|
.
See Category: Factors influencing health status and contact with health services
See Header: Encounter for screening for other viral diseases
ICD-10 (CM) Code and Descriptor
Z11.59 |
Encounter for screening for other viral diseases
This code is considered unacceptable as a principal diagnosis.
|
Z1159 utilizaton on OPPS claims.*
Primary ICD10 Code |
ICD10 Position 2 |
ICD10 Position 3 |
ICD10 Position 4 |
ICD10 Position 5 |
ICD10 Position 6 |
ICD10 Position 7 |
ICD10 Position 8 |
ICD10 Position 9 |
ICD10 Position 10 |
13.91%
|
16.70%
|
15.70%
|
13.05%
|
10.46%
|
9.00%
|
7.59%
|
4.27%
|
2.67%
|
1.92%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z11.59*:
CPT |
Description |
Number of Claims |
Sum Performed |
U0003
|
COV-19 AMP PRB HGH THRUPUT |
115,725
|
115,798
|
U0005
|
INFEC AGEN DETEC AMPLI PROBE |
109,407
|
109,519
|
C9803
|
HOPD COVID-19 SPEC COLLECT |
61,883
|
61,966
|
86803
|
HEPATITIS C AB TEST |
56,839
|
56,843
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
53,835
|
53,950
|
U0004
|
COV-19 TEST NON-CDC HGH THRU |
44,984
|
45,005
|
G2024
|
SPEC COLL SNF/LAB COVID-19 |
43,349
|
43,551
|
87426
|
SARSCOV CORONAVIRUS AG IA |
42,776
|
42,929
|
80053
|
COMPREHEN METABOLIC PANEL |
41,883
|
41,883
|
80061
|
LIPID PANEL |
40,291
|
40,292
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
29,083
|
29,086
|
87635
|
SARS-COV-2 COVID-19 AMP PRB |
24,289
|
24,305
|
84443
|
ASSAY THYROID STIM HORMONE |
21,962
|
21,969
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
21,556
|
21,559
|
U0002
|
COVID-19 LAB TEST NON-CDC |
18,250
|
18,328
|
G0472
|
HEP C SCREEN HIGH RISK/OTHER |
17,918
|
17,918
|
80048
|
METABOLIC PANEL TOTAL CA |
10,757
|
10,759
|
82306
|
VITAMIN D 25 HYDROXY |
9,671
|
9,672
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
8,958
|
8,984
|
85027
|
COMPLETE CBC AUTOMATED |
7,886
|
7,886
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z11.59 related to the following DRG Codes:
951
|